Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction

Recruiting Observational Study
Heart Failure, Diastolic
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
University Medical Center Groningen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Heart failure (HF) with a left ventricular ejection fraction (LVEF) \>0.40 is a large medical problem, for which no drug or device has a recommendation in current HF guidelines. The prevalence of mortality and HF hospitalizations in HF with LVEF \>0.40 is high, but the identification of predictors for increased risk of mortality and HF hospitalizations in this patient category remains difficult. T…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Clinical criteria: 1. Age \>18 years 2. Written informed consent 3. HF with moderate to severe symptoms NYHA II or III 4. Hospitalization or emergency room visit for HF or symptom relief with diuretics 5. Sinus rhythm or AF Echocardiographic criteria: 1. LVEF \>0.40 2. Left a…
Contacts

Michiel Rienstra, MD PhD

0031503612878

m.rienstra@umcg.nl

CONTACT